Skip to main content
logo
Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
13.26
-0.05 (-0.41%)
At close: Apr 27, 2026, 4:00 PM EDT
13.28
+0.02 (0.19%)
After-hours: Apr 27, 2026, 4:10 PM EDT

Enanta Pharmaceuticals Revenue

Enanta Pharmaceuticals had revenue of $18.62M in the quarter ending December 31, 2025, with 9.76% growth. This brings the company's revenue in the last twelve months to $66.98M, up 0.58% year-over-year. In the fiscal year ending September 30, 2025, Enanta Pharmaceuticals had annual revenue of $65.32M, down -3.42%.

Revenue (ttm)
$66.98M
Revenue Growth
+0.58%
P/S Ratio
5.75
Revenue / Employee
$558,167
Employees
120
Market Cap
385.38M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 202565.32M-2.31M-3.42%
Sep 30, 202467.64M-11.57M-14.61%
Sep 30, 202379.20M-6.96M-8.07%
Sep 30, 202286.16M-10.91M-11.24%
Sep 30, 202197.07M-25.40M-20.74%
Sep 30, 2020122.47M-82.72M-40.31%
Sep 30, 2019205.20M-1.43M-0.69%
Sep 30, 2018206.63M103.81M100.97%
Sep 30, 2017102.81M14.55M16.48%
Sep 30, 201688.27M-72.61M-45.13%
Sep 30, 2015160.88M113.14M236.98%
Sep 30, 201447.74M15.69M48.94%
Sep 30, 201332.05M-9.65M-23.15%
Sep 30, 201241.71M-176.00K-0.42%
Sep 30, 201141.88M19.12M83.99%
Sep 30, 201022.76M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Puma Biotechnology228.37M
Niagen Bioscience129.42M
Century Therapeutics109.16M
Autolus Therapeutics75.39M
X4 Pharmaceuticals35.11M
Lineage Cell Therapeutics14.56M
Opus Genetics14.20M
YD Bio510.36K
Revenue Rankings

ENTA News

More News